$SBIG
springbig Holdings Inc Stock $sbig

$sbig Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000162828023038706 Filed on November 13, 2023

Income Statement

Concept	2023 Q4	2023 Q3
Revenue	$6.791M	$6.888M
YoY Change	0.5%	-7.62%
Cost Of Revenue	$2.021M	$1.604M
YoY Change	36.55%	-16.11%
Gross Profit	$4.770M	$5.284M
YoY Change	-9.61%	-4.69%
Gross Profit Margin	70.24%	76.71%
Selling, General & Admin	$5.091M	$6.064M
YoY Change	-26.37%	-3.59%
% of Gross Profit	106.73%	114.76%
Research & Development	$1.754M	$1.912M
YoY Change	-41.44%	-31.98%
% of Gross Profit	36.77%	36.18%
Depreciation & Amortization	$72.00K	$100.0K
YoY Change	5.88%	49.25%
% of Gross Profit	1.51%	1.89%
Operating Expenses	$6.917M	$7.976M
YoY Change	-30.66%	-12.36%
Operating Profit	-$2.147M	-$2.692M
YoY Change	-54.31%	-24.32%
Interest Expense	-$1.126M	-$400.0K
YoY Change	267.97%	27.8%
% of Operating Profit
Other Income/Expense, Net	$76.00K	$350.0K
YoY Change	-83.73%	-56.84%
Pretax Income	-$3.197M	-$2.740M
YoY Change	-29.55%	-1856.41%
Income Tax	$4.000K	$0.00
% Of Pretax Income
Net Earnings	-$3.201M	-$2.742M
YoY Change	-29.51%	-10.36%
Net Earnings / Revenue	-47.14%	-39.81%
Basic Earnings Per Share		-$0.07
Diluted Earnings Per Share	-$0.07	-$0.07
COMMON SHARES
Basic Shares Outstanding	44.05M shares	41.90M shares
Diluted Shares Outstanding		41.90M shares

Balance Sheet

Concept	2023 Q4	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$331.0K	$290.0K
YoY Change	-90.67%	-95.74%
Cash & Equivalents	$300.0K	$300.0K
Short-Term Investments
Other Short-Term Assets	$893.0K	$1.210M
YoY Change	-40.66%	-50.1%
Inventory
Prepaid Expenses
Receivables	$3.221M	$3.871M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$4.445M	$5.666M
YoY Change	-46.27%	-60.39%
LONG-TERM ASSETS
Property, Plant & Equipment	$660.0K	$425.0K
YoY Change	-41.33%	-2.07%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$660.0K	$1.216M
YoY Change	-52.31%	76.23%
TOTAL ASSETS
Total Short-Term Assets	$4.445M	$5.666M
Total Long-Term Assets	$660.0K	$1.216M
Total Assets	$5.105M	$6.882M
YoY Change	-47.14%	-54.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.925M	$2.622M
YoY Change	176.99%	110.43%
Accrued Expenses	$2.419M	$3.230M
YoY Change	-19.87%	140.69%
Deferred Revenue	$0.00	$35.00K
YoY Change	-100.0%	-89.39%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$4.360M	$4.560M
YoY Change	-20.01%	-8.78%
Total Short-Term Liabilities	$13.55M	$12.51M
YoY Change	31.9%	37.62%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Other Long-Term Liabilities	$228.0K	$230.0K
YoY Change	-65.14%	-71.43%
Total Long-Term Liabilities	$228.0K	$230.0K
YoY Change	-93.84%	-96.04%
TOTAL LIABILITIES
Total Short-Term Liabilities	$13.55M	$12.51M
Total Long-Term Liabilities	$228.0K	$230.0K
Total Liabilities	$13.78M	$12.75M
YoY Change	-1.42%	-14.44%
SHAREHOLDERS EQUITY
Retained Earnings	-$36.60M	-$33.40M
YoY Change	39.16%	53.21%
Common Stock	$4.000K	$4.000K
YoY Change	33.33%	33.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$8.674M	-$5.865M
YoY Change
Total Liabilities & Shareholders Equity	$5.105M	$6.882M
YoY Change	-47.14%	-54.11%

Cashflow Statement

Concept	2023 Q4	2023 Q3
OPERATING ACTIVITIES
Net Income	-$3.201M	-$2.742M
YoY Change	-29.51%	-10.36%
Depreciation, Depletion And Amortization	$72.00K	$100.0K
YoY Change	5.88%	49.25%
Cash From Operating Activities	-$506.0K	-$910.0K
YoY Change	-77.0%	-87.65%
INVESTING ACTIVITIES
Capital Expenditures	$101.0K	$170.0K
YoY Change	818.18%	-666.67%
Acquisitions
YoY Change
Other Investing Activities	$10.00K	$0.00
YoY Change	-433.33%	-100.0%
Cash From Investing Activities	-$91.00K	-$170.0K
YoY Change	550.0%	372.22%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	642.0K	640.0K
YoY Change	-161.32%	2033.33%
NET CHANGE
Cash From Operating Activities	-506.0K	-910.0K
Cash From Investing Activities	-91.00K	-170.0K
Cash From Financing Activities	642.0K	640.0K
Net Change In Cash	45.00K	-440.0K
YoY Change	-101.38%	-94.03%
FREE CASH FLOW
Cash From Operating Activities	-$506.0K	-$910.0K
Capital Expenditures	$101.0K	$170.0K
Free Cash Flow	-$607.0K	-$1.080M
YoY Change	-72.55%	-85.28%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	6528000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	9103000	usd
CY2023Q3	us-gaap	Research And Development Expense Software Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost	1912000	usd
CY2022Q3	us-gaap	Research And Development Expense Software Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost	2811000	usd
	us-gaap	Gross Profit GrossProfit	14650000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8790000	usd
	us-gaap	Operating Expenses OperatingExpenses	26251000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-11601000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8535000	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20928363	shares
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.21
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.41
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.41
CY2023Q3	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Noncurrent FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossNoncurrent	269000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Noncurrent FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossNoncurrent	259000	usd
CY2023Q3	us-gaap	Assets Assets	6882000	usd
CY2022Q4	us-gaap	Assets Assets	9657000	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	2622000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1056000	usd
CY2023Q3	wdq	Accrued Expense And Other Liabilities Current AccruedExpenseAndOtherLiabilitiesCurrent	2376000	usd
CY2022Q4	wdq	Accrued Expense And Other Liabilities Current AccruedExpenseAndOtherLiabilitiesCurrent	2554000	usd
CY2023Q3	wdq	Accounts Payable Cash Advance Current AccountsPayableCashAdvanceCurrent	780000	usd
CY2022Q4	wdq	Accounts Payable Cash Advance Current AccountsPayableCashAdvanceCurrent	0	usd
CY2023Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	4560000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	5451000	usd
CY2023Q3	wdq	Social Security Tax Employer Deferral Cares Act SocialSecurityTaxEmployerDeferralCARESAct	1751000	usd
CY2022Q4	wdq	Social Security Tax Employer Deferral Cares Act SocialSecurityTaxEmployerDeferralCARESAct	0	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	35000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	291000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	12514000	usd
CY2023Q3	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	0	usd
CY2022Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	2814000	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	153000	usd
CY2023Q3	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	80000	usd
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	338000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	12747000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	13285000	usd
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43478502	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43478502	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	21259000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19859000	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	1604000	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	1688000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	4465000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	5209000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	5284000	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	5544000	usd
	us-gaap	Gross Profit GrossProfit	16794000	usd
CY2023Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1864000	usd
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3075000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10202000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	7976000	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	9101000	usd
	us-gaap	Operating Expenses OperatingExpenses	22987000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2692000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3557000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6193000	usd
CY2023Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	3000	usd
CY2022Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	7000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	17000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	7000	usd
CY2023Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	400000	usd
CY2022Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	320000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	1114000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	632000	usd
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	347000	usd
CY2022Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	811000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	258000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	3691000	usd
CY2023Q3	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-2742000	usd
CY2022Q3	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-3059000	usd
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-7032000	usd
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-8535000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2742000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-3059000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7032000	usd
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41897995	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41897995	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25629910	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25629910	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33452502	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33452502	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20928363	shares
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-3643000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	239000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	18000	usd
CY2023Q3	wdq	Stock Issued During Period Value Settlement Of Litigation StockIssuedDuringPeriodValueSettlementOfLitigation	263000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2742000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-5865000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-3628000	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	606000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	274000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2384000	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1250000	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	18000	usd
	wdq	Stock Issued During Period Value Settlement Of Litigation StockIssuedDuringPeriodValueSettlementOfLitigation	263000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7032000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-5865000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	3127000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	0	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	30000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-3059000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	98000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	4459000	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1226000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	112000	usd
	wdq	Stock Issued During Period Value Reverse Recapitalization StockIssuedDuringPeriodValueReverseRecapitalization	2836000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8535000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	98000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7032000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8535000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	199000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	191000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	633000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	146000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	606000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1226000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	833000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	280000	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-13000	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	27000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	393000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	0	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	258000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	3691000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1815000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1990000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-292000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1499000	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-44000	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-16000	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	1558000	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	1630000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-403000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	0	usd
	wdq	Increase Decrease In Social Security Tax Employer Deferral Cares Act IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct	-1751000	usd
	wdq	Increase Decrease In Social Security Tax Employer Deferral Cares Act IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct	0	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-256000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-120000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3468000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12318000	usd
	wdq	Origination Of Notes Receivable OriginationOfNotesReceivable	10000	usd
	wdq	Origination Of Notes Receivable OriginationOfNotesReceivable	256000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	249000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	143000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-259000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-399000	usd
	wdq	Proceeds From Reverse Recapitalization ProceedsFromReverseRecapitalization	0	usd
	wdq	Proceeds From Reverse Recapitalization ProceedsFromReverseRecapitalization	10185000	usd
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	1000000	usd
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	0	usd
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	220000	usd
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	0	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	7000000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	125000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	3088000	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2661000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	278000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	274000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	112000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	474000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	17297000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-3253000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	4580000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3546000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2227000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	293000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6807000	usd
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	1250000	usd
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	7305000	usd
	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	0	usd
	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	4496000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	165000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
	wdq	Stock Issued Legal Settlements StockIssuedLegalSettlements	263000	usd
	wdq	Stock Issued Legal Settlements StockIssuedLegalSettlements	0	usd
	wdq	Stock Issued Professional Fees StockIssuedProfessionalFees	18000	usd
	wdq	Stock Issued Professional Fees StockIssuedProfessionalFees	0	usd
	wdq	Cost Of Equity Issuance Deducted From Proceeds CostOfEquityIssuanceDeductedFromProceeds	342000	usd
	wdq	Cost Of Equity Issuance Deducted From Proceeds CostOfEquityIssuanceDeductedFromProceeds	0	usd
	us-gaap	Interest Paid Net InterestPaidNet	467000	usd
	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2023Q3	wdq	Number Of Subsidiaries NumberOfSubsidiaries	1	subsidiary
CY2022Q2	wdq	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	0.59289
CY2022Q2	wdq	Proceeds From Reverse Recapitalization Transaction ProceedsFromReverseRecapitalizationTransaction	18800000	usd
CY2022Q2	wdq	Proceeds From Reverse Recapitalization Transaction Before Closing Costs ProceedsFromReverseRecapitalizationTransactionBeforeClosingCosts	25100000	usd
CY2022Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	7000000	usd
CY2022Q2	wdq	Cash Acquired Through Reverse Recapitalization After Payment To Redeeming Stockholders CashAcquiredThroughReverseRecapitalizationAfterPaymentToRedeemingStockholders	8800000	usd
CY2022Q2	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	6100000	usd
CY2022Q2	wdq	Reverse Recapitalization Accrued Transaction Costs ReverseRecapitalizationAccruedTransactionCosts	8700000	usd
CY2022Q2	wdq	Reverse Recapitalization Net ReverseRecapitalizationNet	10100000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-33400000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3500000	usd
CY2023Q3	wdq	Working Capital WorkingCapital	-6800000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	300000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;text-decoration:underline">Use of Estimates</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. We base our estimates on historical experience and various other assumptions that we believe to be reasonable. We believe that the assumptions and estimates associated with revenue recognition, software development costs, income taxes, equity-based compensation, and the allowance for credit losses have the greatest potential impact on our consolidated financial statements. Therefore, we consider these to be our critical accounting policies and estimates. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Future events and their effects cannot be predicted with certainty; accordingly, accounting estimates require the exercise of judgment. Accounting estimates used in the preparation of these financial statements change as new events occur, as more experience is acquired, as additional information is obtained, and as the operating environment changes. Actual results may differ materially from these estimates.</span></div>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;text-decoration:underline">Concentrations of Credit Risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"> </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Financial instruments that potentially subject us to concentration of credit risk consist principally of cash and cash equivalents and accounts receivable. We place our cash and cash equivalents with high credit-quality financial institutions. Such deposits may be in excess of federally insured limits. To date, we have not experienced any losses on our cash and cash equivalents. We perform periodic evaluations of the relative credit standing of the financial institutions. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We perform ongoing credit evaluations of our customers’ financial condition and require no collateral from our customers. We maintain a credit loss reserve for doubtful accounts. The evaluation of expected losses is based on the probability of default using historical loss rates, as well as adjustments for forward-looking information, including industry and macroeconomic forecasts, as required, on our current accounts receivable balances. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Effective Accounting Pronouncements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> within this Note below for further information.</span></div>
CY2023Q3	us-gaap	Billed Contract Receivables BilledContractReceivables	5346000	usd
CY2022Q4	us-gaap	Billed Contract Receivables BilledContractReceivables	3639000	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	655000	usd
CY2023Q3	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	839000	usd
CY2022Q4	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	731000	usd
CY2023Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	6185000	usd
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	4370000	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2314000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1481000	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3871000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2889000	usd
CY2023Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	400000	usd
CY2022Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	100000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	800000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	300000	usd
CY2023Q3	us-gaap	Prepaid Insurance PrepaidInsurance	605000	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	834000	usd
CY2023Q3	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	509000	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	582000	usd
CY2023Q3	us-gaap	Deposits Assets Current DepositsAssetsCurrent	99000	usd
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	89000	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1213000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1505000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1080000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	831000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	456000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	425000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	375000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P3Y
CY2023Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	100000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	200000	usd
CY2022Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	100000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	200000	usd
CY2022Q2	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Noncurrent FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossNoncurrent	250000	usd
CY2022Q2	wdq	Financing Receivable Before Allowance For Credit Loss Noncurrent Interest Rate FinancingReceivableBeforeAllowanceForCreditLossNoncurrentInterestRate	0.05
CY2023Q3	us-gaap	Interest Income Financing Receivable Before Allowance For Credit Loss InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss	3000	usd
	us-gaap	Interest Income Financing Receivable Before Allowance For Credit Loss InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss	10000	usd
CY2022Q3	us-gaap	Interest Income Financing Receivable Before Allowance For Credit Loss InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss	3000	usd
	us-gaap	Interest Income Financing Receivable Before Allowance For Credit Loss InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss	9000	usd
CY2023Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	818000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1145000	usd
CY2023Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	268000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	148000	usd
CY2023Q3	wdq	Deferred Financial Advisory Fees Current DeferredFinancialAdvisoryFeesCurrent	1000000	usd
CY2022Q4	wdq	Deferred Financial Advisory Fees Current DeferredFinancialAdvisoryFeesCurrent	1006000	usd
CY2023Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	290000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	255000	usd
CY2023Q3	wdq	Accrued Expense And Other Liabilities Current AccruedExpenseAndOtherLiabilitiesCurrent	2376000	usd
CY2022Q4	wdq	Accrued Expense And Other Liabilities Current AccruedExpenseAndOtherLiabilitiesCurrent	2554000	usd
CY2022Q2	wdq	Reverse Recapitalization Cash Paid To Shareholders ReverseRecapitalizationCashPaidToShareholders	191437817	usd
CY2022Q2	wdq	Proceeds From Reverse Recapitalization Transaction ProceedsFromReverseRecapitalizationTransaction	18800000	usd
CY2022Q2	wdq	Proceeds From Reverse Recapitalization Transaction Before Closing Costs ProceedsFromReverseRecapitalizationTransactionBeforeClosingCosts	25100000	usd
CY2022Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	7000000	usd
CY2022Q2	wdq	Cash Acquired Through Reverse Recapitalization After Payment To Redeeming Stockholders CashAcquiredThroughReverseRecapitalizationAfterPaymentToRedeemingStockholders	8800000	usd
CY2022Q2	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	6100000	usd
CY2022Q2	wdq	Cash Acquired Through Reverse Recapitalization After Payment To Redeeming Stockholders CashAcquiredThroughReverseRecapitalizationAfterPaymentToRedeemingStockholders	8771000	usd
CY2022Q2	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	6100000	usd
CY2022Q2	wdq	Proceeds From Reverse Recapitalization Operating Account ProceedsFromReverseRecapitalizationOperatingAccount	264000	usd
CY2022Q2	wdq	Proceeds From Reverse Recapitalization Transaction Before Closing Costs ProceedsFromReverseRecapitalizationTransactionBeforeClosingCosts	25135000	usd
CY2022Q2	wdq	Payments Of Reverse Recapitalization Transaction Costs PaymentsOfReverseRecapitalizationTransactionCosts	6346000	usd
CY2022Q2	wdq	Proceeds From Reverse Recapitalization Transaction ProceedsFromReverseRecapitalizationTransaction	18789000	usd
CY2022Q2	wdq	Reverse Recapitalization Accrued Transaction Costs ReverseRecapitalizationAccruedTransactionCosts	8679000	usd
CY2022Q2	wdq	Reverse Recapitalization Net ReverseRecapitalizationNet	10110000	usd
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	25290270	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	25290270	shares
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	347000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	258000	usd
CY2022Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	800000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	3700000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7232000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19859000	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	1688000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	5209000	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	5544000	usd
	us-gaap	Gross Profit GrossProfit	14650000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6888000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7232000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	21259000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19859000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6888000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7232000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	21259000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19859000	usd
CY2023Q3	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	289000	usd
CY2022Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	333000	usd
CY2022Q4	wdq	Contract With Customer Assets Current ContractWithCustomerAssetsCurrent	333000	usd
CY2021Q4	wdq	Contract With Customer Assets Current ContractWithCustomerAssetsCurrent	364000	usd
	wdq	Contract With Customer Assets Expense Deferred Including Opening Balance ContractWithCustomerAssetsExpenseDeferredIncludingOpeningBalance	127000	usd
CY2022	wdq	Contract With Customer Assets Expense Deferred Including Opening Balance ContractWithCustomerAssetsExpenseDeferredIncludingOpeningBalance	176000	usd
	wdq	Contract With Customer Assets Amounts Expensed During The Year ContractWithCustomerAssetsAmountsExpensedDuringTheYear	171000	usd
CY2022	wdq	Contract With Customer Assets Amounts Expensed During The Year ContractWithCustomerAssetsAmountsExpensedDuringTheYear	207000	usd
CY2023Q3	wdq	Contract With Customer Assets Current ContractWithCustomerAssetsCurrent	289000	usd
CY2022Q4	wdq	Contract With Customer Assets Current ContractWithCustomerAssetsCurrent	333000	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	35000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	291000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	291000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	450000	usd
	wdq	Contract With Customer Liability Amounts Invoiced During The Year ContractWithCustomerLiabilityAmountsInvoicedDuringTheYear	14975000	usd
CY2022	wdq	Contract With Customer Liability Amounts Invoiced During The Year ContractWithCustomerLiabilityAmountsInvoicedDuringTheYear	18310000	usd
	wdq	Contract With Customer Liability Revenue Recognized Including Opening Balance ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance	15231000	usd
CY2022	wdq	Contract With Customer Liability Revenue Recognized Including Opening Balance ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance	18469000	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	35000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	291000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3394753	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.57
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	3250236	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y6M14D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.54
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	727233	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.38
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	25876	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.82
	wdq	Share Based Compensation Arrangements By Share Based Payment Award Options Cancelled In Period ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCancelledInPeriod	0	shares
	wdq	Share Based Compensation Arrangements By Share Based Payment Award Options Cancelled In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCancelledInPeriodWeightedAverageExercisePrice	0
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2641644	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.62
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2569385	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y18D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.61
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	162000	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2569385	shares
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
CY2023Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	91000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	1.97
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	1.97
CY2023Q3	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P98M
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	522000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	750000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	390000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	465000	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	153000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	316000	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	543000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	781000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	343000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	382000	usd
CY2023Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	117000	usd
CY2022Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	129000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	343000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	357000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	165000	usd
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P21Y2M12D
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0699
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	100000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	371000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	50000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	50000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	8000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	579000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	36000	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	543000	usd
CY2023Q3	us-gaap	Litigation Reserve LitigationReserve	800000	usd
CY2023Q3	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	100000	usd
CY2023Q3	wdq	Stock Issued During Period Value Settlement Of Litigation StockIssuedDuringPeriodValueSettlementOfLitigation	300000	usd
CY2023Q3	us-gaap	Litigation Reserve LitigationReserve	400000	usd
CY2023Q3	wdq	Litigation Settlement Amount Awarded To Other Party Periodic Payments Amount LitigationSettlementAmountAwardedToOtherPartyPeriodicPaymentsAmount	40000	usd
	wdq	Proceeds From Social Security Tax Employer Deferral Cares Act ProceedsFromSocialSecurityTaxEmployerDeferralCARESAct	2000000	usd
	wdq	Operating Expenses Offset Social Security Tax Employer Deferral Cares Act OperatingExpensesOffsetSocialSecurityTaxEmployerDeferralCARESAct	300000	usd
CY2023Q3	wdq	Social Security Tax Employer Deferral Cares Act SocialSecurityTaxEmployerDeferralCARESAct	1800000	usd
CY2023Q3	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	80000	usd
CY2022Q2	wdq	Preferred Stock Convertible Conversion Trigger Amount Of Initial Public Offering PreferredStockConvertibleConversionTriggerAmountOfInitialPublicOffering	50000000	usd
CY2022Q2	wdq	Preferred Stock Convertible Conversion Trigger Percent Of Total Votes PreferredStockConvertibleConversionTriggerPercentOfTotalVotes	0.63
CY2022Q2	us-gaap	Preferred Stock Convertible Conversion Ratio PreferredStockConvertibleConversionRatio	1
CY2022Q2	wdq	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	0.59289
CY2022Q2	wdq	Sponsor Escrow Agreement Sponsor Earnout Shares SponsorEscrowAgreementSponsorEarnoutShares	1000000	shares
CY2022Q2	wdq	Sponsor Escrow Agreement Release Of Shares Stock Price Trigger SponsorEscrowAgreementReleaseOfSharesStockPriceTrigger	12.00
CY2022Q2	wdq	Sponsor Escrow Agreement Stock Price Trigger Threshold Trading Days SponsorEscrowAgreementStockPriceTriggerThresholdTradingDays	20	day
CY2022Q2	wdq	Sponsor Escrow Agreement Stock Price Trigger Threshold Trading Day Period SponsorEscrowAgreementStockPriceTriggerThresholdTradingDayPeriod	30	day
CY2022Q2	us-gaap	Capital Units Authorized CapitalUnitsAuthorized	350000000	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43478502	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	43478502	shares
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2742000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-3059000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7032000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8535000	usd
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41897995	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41897995	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25629910	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25629910	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33452502	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33452502	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20928363	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20928363	shares
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.21
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.41
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.41
CY2023Q3	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	84000	usd
	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	373000	usd
CY2022Q3	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	64000	usd
	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	160000	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001628280-23-038706-index-headers.html	Edgar Link	pending
0001628280-23-038706-index.html	Edgar Link	pending
0001628280-23-038706.txt	Edgar Link	pending
0001628280-23-038706-xbrl.zip	Edgar Link	pending
agileagreement.htm	Edgar Link	pending
agileagreement001.jpg	Edgar Link	pending
agileagreement002.jpg	Edgar Link	pending
agileagreement003.jpg	Edgar Link	pending
agileagreement004.jpg	Edgar Link	pending
agileagreement005.jpg	Edgar Link	pending
agileagreement006.jpg	Edgar Link	pending
agileagreement007.jpg	Edgar Link	pending
agileagreement008.jpg	Edgar Link	pending
agileagreement009.jpg	Edgar Link	pending
cedaragreementsigned.htm	Edgar Link	pending
cedaragreementsigned001.jpg	Edgar Link	pending
cedaragreementsigned002.jpg	Edgar Link	pending
cedaragreementsigned003.jpg	Edgar Link	pending
cedaragreementsigned004.jpg	Edgar Link	pending
cedaragreementsigned005.jpg	Edgar Link	pending
cedaragreementsigned006.jpg	Edgar Link	pending
cedaragreementsigned007.jpg	Edgar Link	pending
cedaragreementsigned008.jpg	Edgar Link	pending
cedaragreementsigned009.jpg	Edgar Link	pending
exhibit321ceo906certificat.htm	Edgar Link	pending
exhibit322cfo906certificat.htm	Edgar Link	pending
exhibit331-ceo302certifica.htm	Edgar Link	pending
exhibit332-cfo302certifica.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
wdq-20230930.htm	Edgar Link	pending
wdq-20230930.xsd	Edgar Link	pending
wdq-20230930_cal.xml	Edgar Link	unprocessable
wdq-20230930_def.xml	Edgar Link	unprocessable
wdq-20230930_lab.xml	Edgar Link	unprocessable
wdq-20230930_pre.xml	Edgar Link	unprocessable
wdq-20230930_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SBIG
springbig Holdings Inc Stock $sbig

2023 Q4 Form 10-Q Financial Statement

#000162828023038706 Filed on November 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SBIG springbig Holdings Inc Stock $sbig

2023 Q4 Form 10-Q Financial Statement

#000162828023038706 Filed on November 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SBIG
springbig Holdings Inc Stock $sbig